United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - amiloride hydrochloride - oral solution - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - amiloride hydrochloride - oral solution - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - amiloride hydrochloride - oral solution - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

icarus pharmaceuticals ltd - amiloride hydrochloride - oral solution - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pharma-z ltd - amiloride hydrochloride - oral solution - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - amiloride hydrochloride - oral solution - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

essential pharma ltd - amiloride hydrochloride - oral solution - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - amiloride hydrochloride - oral solution - 1mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; lactose monohydrate; microcrystalline cellulose; magnesium stearate - indications as at 15 july 1998 : kaluril's main indication is as concomitant therapy with diuretics to conserve potassium during periods of vigorous diuresis and during long-term maintenance therapy with thiazides or other more potent diuretics. kaluril when used alone, has mild diuretic and antihypertensive activity. oedema of cardiac origin. although kaluril alone may provide adequate diuresis for some patients with oedema of cardiac origin, it is primarily indicated for concomitant use in patients receiving thiazides or more potent saluretic diuretic agents. in these patients it may provide increased sodium, chloride and water excretion and decreased potassium excretion. the positive effect of kaluril on potassium balance may be especially important for digitalised cardiac patients, in whom potassium depletion sensitises or exaggerates the response of the heart to the toxic effects of digitalis (e.g. increased ventricular irritability), which may precipitate digitalis intoxication with potentially seriou

Zimbabwe - English - Medicines Control Authority

caps pvt ltd - amiloride hydrochloride - tablet; oral - 5mg